Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/INNATE-PHARMA-35620/news/Innate-Pharma-Opening-of-the-Phase-I-II-trial-of-IPH2201-in-combination-with-ibrutinib-in-patients-21150572/?utm_source=whatsapp&utm_medium=social&utm_campaign=share